Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88.1M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
+7.55M
-
Total reported value, excl. options
-
$262M
-
Value change
-
+$120M
-
Number of buys
-
54
-
Number of sells
-
-7
-
Price
-
$14.21
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2020
68 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q2 2020.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 88.1M outstanding shares and own 20.98% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3.46M shares), BVF INC/IL (3.23M shares), Canaan Partners X LLC (2.66M shares), BOXER CAPITAL, LLC (2.2M shares), Avidity Partners Management LP (1.33M shares), Point72 Asset Management, L.P. (1.01M shares), Alphabet Inc. (753K shares), BlackRock Inc. (729K shares), VANGUARD GROUP INC (500K shares), and CITADEL ADVISORS LLC (248K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.